Physical agents for controlling microbial growth include all of the following except

A. Lack of membrane-bound organelles: Prokaryotic cells do not have membrane-bound organelles such as mitochondria, endoplasmic reticulum, or Golgi apparatus. All cellular processes, including energy production, protein synthesis, and DNA replication, occur in the cytoplasm or at the plasma membrane, which allows for rapid metabolic activity but limits compartmentalization.

B. Presence of mitochondria: Mitochondria are membrane-bound organelles responsible for aerobic respiration and ATP production in eukaryotic cells. Prokaryotes lack mitochondria and instead carry out energy-producing processes across the plasma membrane.

C. Multiple nuclei: Prokaryotic cells contain a single, circular chromosome located in the nucleoid region, not multiple nuclei. Multiple nuclei are characteristic of certain eukaryotic cells, such as skeletal muscle fibers or some fungal hyphae.

A. blocks penetration: Blocking penetration prevents viruses from entering host cells. Nucleotide analogs do not interfere with viral entry; instead, they act after the virus has already penetrated the host cell.

B. inhibits peptidoglycan cross-linking: Peptidoglycan is a component of bacterial cell walls, not viruses. Antibiotics like penicillin target this process, but nucleotide analogs target viral nucleic acid synthesis, not bacterial cell walls.

C. bonds to ergosterol in the cell membrane: Binding to ergosterol is the mechanism of action for antifungal drugs such as amphotericin B. Nucleotide analogs do not interact with membranes or sterols.

D. blocks DNA replication: Nucleotide analogs resemble natural nucleotides and are incorporated into viral DNA or RNA during replication. Once incorporated, they can terminate chain elongation or cause mutations, effectively inhibiting viral DNA replication and viral proliferation.

E. blocks maturation: Blocking maturation interferes with viral assembly or processing of viral proteins, a mechanism seen with protease inhibitors. Nucleotide analogs act earlier in the replication cycle by directly targeting nucleic acid synthesis rather than late-stage viral maturation.